ASGARD Advises Avadim Health, Inc. on $60 Million Financing

NEW YORK, /PRNewswire/ -- ASGARD Partners & Co. ("ASGARD"), a leading middle-market investment and advisory firm, is pleased to announce today that it has acted as exclusive advisor to Avadim Health, Inc. ("Avadim Health"), the Bionome Therapies™ life sciences company, on its $40 million debt financing round with an additional accordion facility of up to $20 million. Hayfin Capital Management was the sole investor in the financing.

Steve Woody, Chairman and CEO of Avadim Health, stated, "The financing represents the accomplishment of a major milestone in our overall capitalization plan. We are pleased to partner with Hayfin and their investment experience in our industry. Hayfin's investment will allow us to continue to drive execution and support the company's strong growth trajectory. We would also like to thank ASGARD for their relentless support in helping us manage the process to close this transaction. ASGARD's strong understanding of the life sciences sector and its ability to help navigate structuring and financial challenges resulted in a great outcome for all parties."

"We are proud to have been able to help Avadim Health as it continues to build a world-class company and a fantastic brand in the healthcare and consumer spaces with their family of products. With this financing, we are excited to see the Company continue to grow and be in a position to serve even more customers and improve their lives. Working with Steve and the rest of his team has been a real privilege," said Nicholas Desjardins, Partner at ASGARD.

About Avadim Health, Inc.:
Based in Asheville, North Carolina (USA), Avadim Health, Inc. is a rapidly growing life sciences company built around the concept of serving. With a mission to change lives and transform communities, the company identifies unmet needs and addresses them in a way nobody else has. Avadim Health offers a portfolio of advanced, safe solutions, and has a strong pipeline across a broad range of health and wellness areas.

About ASGARD:    
ASGARD Partners & Co. is a next generation financial firm combining private equity investments and capital markets advisory into one platform to better and more effectively serve portfolio companies, clients and investors. ASGARD believes business is a powerful platform that can change the world for the better and is committed to serving entrepreneurs, companies, and investors that share this belief. The partners at ASGARD have collectively arranged and advised on more than $100 billion in transactions and have proven expertise across a wide spectrum of advisory services. ASGARD brings multi-functional capabilities to its clients and enables them to navigate their capital and growth decisions effectively. For more information, visit https://asgardpartners.com.

All private placements of securities are offered through, VENTURE.co Brokerage Services LLC Member: FINRA/SIPC. ASGARD Partners & Co., LLC and VENTURE.co are independent and not affiliated. None of the aforementioned firms provide legal, tax or investment advice and are not authorized to do so. Information about any securities offering should not be considered complete and is qualified by the full offering documents corresponding to a particular project financing. This email does not constitute an offer of, or the solicitation of an offer to buy or subscribe for, any securities to any person in any jurisdiction to whom or in which such offer or solicitation is unlawful. All communications by ASGARD Partners & Co., LLC and  VENTURE.co or any of its directors, officers, employees, representatives, affiliates or agents, are modified by the Terms of Use and Privacy Policy posted on the website at ASGARD Partners & Co., LLC and VENTURE.co.

View original content to download multimedia:http://www.prnewswire.com/news-releases/asgard-advises-avadim-health-inc-on-60-million-financing-300728658.html

SOURCE ASGARD Partners & Co.